<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>FDA suggested dosing pattern of remdesivir in COVID-19 in different categories of patients</p>
 </caption>
 <table frame="hsides" rules="groups" cellpadding="10" cellspacing="0">
  <thead>
   <tr>
    <th align="left" valign="bottom" rowspan="1" colspan="1">
     <italic>Category of patient</italic>
    </th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">
     <italic>Body weight</italic>
    </th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">
     <italic>Loading dose</italic>
    </th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">
     <italic>Maintenance dose</italic>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Adult or pediatric patients requiring invasive mechanical ventilation and/or ECMO</td>
    <td align="left" valign="top" rowspan="1" colspan="1">≥40 kg</td>
    <td align="left" valign="top" rowspan="1" colspan="1">200 mg infused intravenously over 30 to 120 minutes on day 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">100 mg infused intravenously over 30 to 120 minutes for 9 days (days 2 through 10).</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Adult or pediatric patients not requiring invasive mechanical ventilation and/or ECMO</td>
    <td align="left" valign="top" rowspan="1" colspan="1">≥40 kg</td>
    <td align="left" valign="top" rowspan="1" colspan="1">200 mg infused intravenously over 30 to 120 minutes on day 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">100 mg infused intravenously over 30 to 120 minutes for 9 days (days 2 through 5). If no improvement, may be extended up to 10 days.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Pediatric patients requiring invasive mechanical ventilation and/or ECMO</td>
    <td align="left" valign="top" rowspan="1" colspan="1">3.5 to 40 kg</td>
    <td align="left" valign="top" rowspan="1" colspan="1">5 mg/kg IV (infused over 30 to 120 minutes) on day 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">2.5 mg/kg IV (infused over 30 to 120 minutes) once daily for 9 days (days 2 through 10)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Pediatric patients not requiring invasive mechanical ventilation and/or ECMO</td>
    <td align="left" valign="top" rowspan="1" colspan="1">3.5 to 40 kg</td>
    <td align="left" valign="top" rowspan="1" colspan="1">5 mg/kg IV (infused over 30 to 120 minutes) on day</td>
    <td align="left" valign="top" rowspan="1" colspan="1">2.5 mg/kg IV (infused over 30 to 120 minutes) once daily for 4 days (days 2 through 5). If no improvement, may be extended up to 10 days.</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Remdesivir can be used at any time after onset of symptoms in hospitalized patients</p>
  </fn>
  <fn>
   <p>All patients must have an estimated glomerular filtration rate (eGFR) determined before dosing</p>
  </fn>
  <fn>
   <p>Known serious adverse effects are infusion-related reaction, increased risk of transaminase elevations. Common adverse effects are nausea, diarrhea, rash hypotension etc.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
